Categories Earnings, Health Care
Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates
Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in sales and adjusted profit. The results also exceeded Wall Street’s estimates.
Total reported sales increased 7.4% year-over-year to $11.14 billion in the second quarter. Organic sales grew 6.9%, or 7.5% excluding COVID-19 testing-related sales.
Adjusted earnings rose to $1.26 per share in Q2 from $1.14 per share in the year-ago quarter and came in slightly above analysts’ expectations. Unadjusted profit rose sharply to $1.78 billion or $1.01 per share in the second quarter from $1.30 billion or $0.74 per share in Q2 2024.
“Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly expanded our margin profiles, and continued to advance key programs through our new product pipeline,” said Robert Ford, chief executive officer of Abbott.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
